Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
30 August 2017 09:07
A new drug may carry a boost for heart attack and cancer patients
A study has discovered that a new drug could help cut cancer deaths, as well as potentially reduce the risk of heart attacks.
More than 10,000 patients, all of whom had previously had a heart attack but had not been diagnosed with cancer, took part in a trial using the anti-inflammatory Canakinumab.
They were treated once every three months and monitored for four years.
Milestone in a long journey
It was found that there was a 15% reduction in the risk of heart attacks and strokes, while cancer deaths were cut in half.
Commenting on the study, which was presented at the European Society of Cardiology meeting in Barcelona, Dr Paul Ridker of Brigham and Women's Hospital in Boston said it "represents a milestone in a long journey".
"For the first time, we've been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk," he said.
"This has far-reaching implications. It tells us that by leveraging an entirely new way to treat patients - targeting inflammation - we may be able to significantly improve outcomes for certain very high-risk populations."
He added that further research is needed into the drug's effects on cancer.
A platform for the future
Gary Gibbons, director of the National Heart, Lung and Blood Institute, said the results provide a platform on which to carry out further trials and research.
He added that while the trial offers "compelling evidence" that targeting inflammation efficacy is preventing recurrent cardiovascular events, the Institute is also looking forward to findings from additional trials, including the NHLBI-funded Cardiovascular Inflammation Reduction Trial, to help further refine the best therapeutic strategies for preventing heart disease.
People who have undergone cancer treatment in the past can arrange specialist medical travel insurance when taking holidays.
17 January 2019
Campaigners are protesting outside the High Court in London as the legal challenge against Heathrow Airport's controversial expansion ramps up.
[more...]
16 January 2019
A new way to predict a woman's risk of breast cancer has been unveiled by scientists - and it's the most comprehensive method yet.
15 January 2019
NHS commissioners could be slapped with a £2,500 fine for every patient left waiting more than a year for vital care, new proposals suggest.
12 January 2019
All UK airports should buy anti-drone technology and not rely on the Royal Air Force to help out, Defence Secretary Gavin Williamson has said.
10 January 2019
The military was brought in on Tuesday night after police officers saw a drone operating at Heathrow Airport, forcing departures to be suspended for an hour.
11 January 2019
A so-called "drug sponge" that mops up leftover drugs from cancer treatment could improve the effectiveness of chemotherapy, new research has claimed.
09 January 2019
A hormone released during exercise could help protect the brain from Alzheimer's disease, new research suggests.
08 January 2019
Ryanair has been labelled the worst airline operating in the UK for the sixth year running in a leading consumer group survey.
05 January 2019
Anti-drone technology will be deployed at the UK's two busiest airports in response to the disruption caused before Christmas.
04 January 2019
A new cancer-detecting breathalyser test is being trialled in the UK - in a move that could revolutionise the way the disease is diagnosed.
03 January 2019
The average 10-year-old child will have already eaten more sugar in their life than the maximum amount recommended for 18-year-olds, a new study reveals.
01 January 2019
The number of travellers satisfied with flying has fallen over the last two years over frustration with how airlines handle complaints, new research reveals.